A randomized trial comparing the safety and efficacy of adriamycin and cyclophosphamide followed by taxol (AC-T) to that of adriamycin and cyclophosphamide followed by taxol plus herceptin (AC-T+HC) in node-positive breast cancer patients who have tumors. PI: Howard